Myriad Genetics
Offers hereditary cancer, tumor profiling, prenatal, and GeneSight pharmacogenomic tests.
$3.16
After-hours close+0.02 (+0.48%)
At close$3.15(−1.10%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.21 | — | — |
| Jul 2026 | −$0.06 | −$0.25 | −331.9% |
| May 2026 | −$0.06 | −$0.09 | −50.0% |
| Feb 2026 | −$0.02 | $0.04 | +300.0% |
| Nov 2025 | −$0.01 | −$0.13 | −1,200.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | −$0.21 | — | — | $191.3M | — | — |
| Jul 30, 2026 | −$0.06 | −$0.25 | −331.9% | $206.0M | $190.7M | −7.4% |
| May 5, 2026 | −$0.06 | −$0.09 | −50.0% | $202.4M | $200.4M | −1.0% |
| Feb 23, 2026 | −$0.02 | $0.04 | +300.0% | $207.4M | $209.8M | +1.1% |
| Nov 3, 2025 | −$0.01 | −$0.13 | −1,200.0% | $207.0M | $205.7M | −0.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 24, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 3, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 1, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 2, 2021 | ||||||
| Aug 3, 2021 | ||||||
| May 3, 2021 | ||||||
| Feb 23, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 13, 2020 | ||||||
| May 5, 2020 | ||||||
| Feb 6, 2020 | ||||||
| Nov 4, 2019 | ||||||
| Aug 13, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 5, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 21, 2018 | ||||||
| May 8, 2018 | ||||||
| Feb 6, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 2, 2017 | ||||||
| Feb 7, 2017 | ||||||
| Nov 1, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 3, 2016 | ||||||
| Feb 2, 2016 | ||||||
| Nov 3, 2015 | ||||||
| Aug 11, 2015 | ||||||